Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed

This study has been completed.

Study NCT00006006 Information provided by National Cancer Institute (NCI)

First Received: July 5, 2000 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Liver Cancer

Additional conditions recognized in this trial

Liver Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial